Company news
Australian Clinical Labs Ltd (ASX:ACL) news
Australian Clinical Labs Ltd news releases on 6ix. Latest, Aug 16, 2026: FY26 financial results investor presentation
Press releases & updates
FY26 financial results investor presentation
August 16, 2026
Appointment of new Group CEO
May 27, 2026
Class action proceedings
April 20, 2026
CEO contract update
February 15, 2026
Appendix 4D and 1H26 financial reports
February 15, 2026
ACL 1H26 financial results investor presentation
February 15, 2026
On Market Share Buy Back
October 22, 2025
AIC proceedings - update
September 29, 2025
Appendix 4E and Financial Report 30 June 2025
August 25, 2025
FY25 Results Announcement
August 25, 2025
FY25 Results Presentation
August 25, 2025
Response to ASX Aware Letter
February 27, 2025
Appendix 4D and 1H25 financial statements
February 25, 2025
1H25 financial results investor presentation
February 25, 2025
Sale of Crescent Capital shareholding
September 11, 2024
Notification of buy-back - ACL
August 28, 2024
FY24 financial results investor presentation
August 28, 2024
Appendix 4E and FY24 financial statements
August 28, 2024
FY24 Trading Update
May 21, 2024
Appendix 4D and 1H24 financial reports
February 27, 2024
1H24 investor presentation
February 27, 2024
Notice of withdrawal of offer - Healius Limited
December 21, 2023
HLS:ACCC Rejection&ACL Notice of Intention to Withdraw Offer
December 15, 2023
Intention to withdraw takeover offer for Healius
December 14, 2023
AXX:Accc opposes Australian Clinical Labs' proposed acquis
December 14, 2023
Takeover offer - Healius entitlement offer
November 20, 2023
Fourth Supplementary Bidder's Statement
November 9, 2023
Extension of offer period - notice of variation
October 31, 2023
Takeover offer for Healius - extension of offer period
October 31, 2023
Notice of fulfilment of conditions
October 8, 2023
Third Supplementary Bidder's Statement
October 8, 2023
HLS: Supplementary Target's Statement
September 4, 2023
FY23 investor results presentation
August 21, 2023
Appendix 4E and FY23 financial reports
August 21, 2023
HLS: ACCC Statement of Issues
July 20, 2023
Takeover bid for Healius Ltd- extension of offer period
July 20, 2023
AXX: ACL's proposed acquisition of Healius raises concerns
July 20, 2023
HLS: Directors' Statement re Takeover
May 22, 2023
Response to Healius' Target's Statement
May 22, 2023
Second Supplementary Bidder's Statement
May 22, 2023
HLS: Lodgement of Target's Statement
May 3, 2023
HLS Panel Declines to Conduct Proceedings
April 17, 2023
ASX announcement - Replacement Bidder's Statement
April 14, 2023
Replacement Bidder's Statement
April 14, 2023
First Supplementary Bidder's Statement
April 14, 2023
HLS Panel Receives Application
March 28, 2023
HLS: Off-market takeover bid from ACL
March 19, 2023
Investor Presentation - Takeover Offer for Healius
March 19, 2023
Bidder's Statement in Takeover Offer for Healius
March 19, 2023
Investor Webinar - Takeover Offer for Healius
March 19, 2023